SOUTH SAN FRANCISCO, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are…
Read More
Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Older Adult Age Cohorts in Phase 1 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sep. 29, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
Read More
Kiniksa Announces U.S. Orphan Drug Designation for Mavrilimumab for the Treatment of Giant Cell Arteritis
HAMILTON, Bermuda, Sept. 15, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing…
Read More
US announces free COVID-19 testing in three southern hotspots
The United States on Tuesday announced it was offering free COVID-19 testing to people without symptoms to stem a surge…
Read More
Depakote topamax
Order Medicines & Health Products from Online Pharmacy for Skin, Hair, Heart and all Personal Daily Health. Baby, Men, Women…
Read More
Vaxart Announces Initiation of Bivalent Norovirus Vaccine Phase 1b Clinical Trial
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Mar. 19, 2019– Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered…
Read More
vTv Therapeutics Announces Publication of Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study
HIGH POINT, N.C.–(BUSINESS WIRE)–Jan. 16, 2019– vTv Therapeutics Inc. (Nasdaq: VTVT) today announced the publication of a paper in Science…
Read More
Pulmatrix Announces Positive Final Results from the Phase 1/1b Clinical Trial of Pulmazole – an Inhaled Dry-Powder iSPERSE™ Formulation of Itraconazole
LEXINGTON, Mass., Nov. 21, 2018 /PRNewswire/ — Pulmatrix, Inc. (NASDAQ: PULM) announced the results of the completed first-in-human study of…
Read More